There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Abbott Laboratories (ABT) shows that investor sentiment remained same, with the stock’s consolidated last price to $95.79. The Abbott Laboratories has recorded 280,456 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott’s HeartMate 3™ Heart Pump.
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $95.79 and fluctuated between $96.75 as its day high and $94.50 as its day low. The current market capitalization of Abbott Laboratories is $166.30B. A total of 6.87 million shares were traded on the day, compared to an average of 5.29M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, ABT has seen 4 BUY and 3 SELL insider trades, representing the acquisition of 23,151 and the disposition of 70,000 shares. Over the last 12 months, there were 39 BUYs and 57 SELLs from insiders. Insiders purchased 388,626 shares during that period but sold 359,131.
In the most recent transaction, STARKS DANIEL J sold 50,000 shares of ABT for 94.05 per share on Oct 26. After the transaction, the Director now owns 6,725,316 company shares. In a previous transaction on Aug 08, Wainer Andrea F sold 10,400 shares at 105.03 per share. ABT shares that EXECUTIVE VICE PRESIDENT owns now total 65,027.
Among the insiders who sold shares, STARKS DANIEL J disposed of 50,000 shares on Jul 27 at a per-share price of $113.76. This resulted in the Director holding 6,775,316 shares of ABT after the transaction. In another insider transaction, STARKS DANIEL J sold 50,000 shares at $111.02 per share on May 02. Company shares held by the Director now total 6,825,316.
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Abbott Laboratories pays an annual dividend of $1.99, resulting in a dividend yield of 2.08%, and it has a price to earnings (P/E) ratio of 32.55. ABT’s most recent ex-dividend date was 10/12/2023 when it declared a $0.51 quarterly dividend that was paid in cash on 11/15/2023. Previously, the company paid the dividend on 8/15/2023 with an ex-dividend date of 7/13/2023. The ABT stock dividend was $0.51 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for ABT in the last 3 months, the mean price target is $115.37 with high estimates of $133.00 and low estimates of $100.00. In terms of 52-week highs and lows, ABT has a high of $115.83 and a low of $89.67.
As of this writing, ABT has an earnings estimate of $1.19 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $1.2 per share and a lower estimate of $1.18. The company reported an EPS of $1.08 in the last quarter, which was 2.90% higher than expectations of $1.05.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ABT’s latest balance sheet shows that the firm has $10.25B in Cash & Short Term Investments as of fiscal 2021. There were $19.01B in debt and $13.11B in liabilities at the time. Its Book Value Per Share was $21.59, while its Total Shareholder’s Equity was $36.02B.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABT is Buy with a score of 4.44.